(Q43878341)

English

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

primary sclerosing cholangitis

1 reference

based on heuristic

inferred from title

author name string

Adolf Stiehl

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Gerda Rudolph

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Petra Klöters-Plachky

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Peter Sauer

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Siegfried Walker

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

151-156

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary sclerosing cholangitis: refinement and validation of survival models

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of cholestasis on absorption of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic investigations in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow-up assessment of a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900251-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(01)00251-3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

release_hjwxf66a7rdlnoyqnmktjcl4vu

1 reference

https://api.fatcat.wiki/v0/release/hjwxf66a7rdlnoyqnmktjcl4vu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43878341&oldid=2104100597"